NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults29 Jul 2026
HFCL Limited
Analysts/Institutional Investor Meet/Con. Call Updates
HFCL Limited has announced its Q1 FY27 earnings, with the company reporting its highest ever quarterly revenue, profitability, and order book. The company has also seen strong order inflows and execution across its core segments, with a continued improvement in profitability and progress on strategic initiatives.
NSEPress Release▲ PositiveResults29 Jul 2026
Redington Limited
Press Release
Redington Limited has reported its highest-ever quarterly revenue and profit in Q1 FY27, with consolidated revenue standing at ₹34,966 crore, representing a year-on-year growth of 34%, and profit after tax, excluding exceptional items, increasing 77% to ₹486 crore.
BSECompany Update▲ PositiveResults29 Jul 2026
Redington Ltd
Redington reports record Q1FY27 revenue
Redington Ltd reported record Q1FY27 revenue of ₹34,966 crore, up 34% YoY, with PAT excluding exceptional items reaching ₹486 crore, up 77% YoY.
NSEGeneral Updates▲ PositiveResults29 Jul 2026
TBO Tek Limited
General Updates
TBO Tek Limited has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with a 37% YoY growth in Gross Transaction Value (GTV) and a 25% YoY growth in Adj. EBITDA. The company's organic Hotels + Ancillary business grew 27.3% YoY, while the India Airlines business grew 14.7% YoY. The company's cash and cash equivalents increased by ₹392 Cr from March 31, 2026, driven in part by working capital release.
BSECompany Update▲ PositiveResults29 Jul 2026
TBO TEK Ltd
Please see enclosed the shareholders'' Letter
TBO Tek Ltd delivered a solid quarter with early operating leverage driving margin expansion. Key metrics include a 37% YoY growth in Gross Transaction Value (GTV) to ₹11,154 Cr, with organic GTV up 22% YoY to ₹9,918 Cr. The company's Hotels + Ancillary business grew 27.3% YoY, while the India Airlines business grew 14.7% YoY. Adj. EBITDA grew 25% YoY, with an Adj. EBITDA margin of 18% (organic). Cash and Cash Equivalents were ₹1,984Cr as on 30th June 2026, up ₹392 Cr from 31st March 2026.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults29 Jul 2026
GANESH HOUSING LIMITED
Analysts/Institutional Investor Meet/Con. Call Updates
Ganesh Housing Limited's Q1 FY27 Earnings Conference Call transcript is available on their website, discussing the company's business outlook and financial highlights, with a focus on their diversified real estate platform and strategic initiatives.
NSEPress Release▲ PositiveResults29 Jul 2026
TBO Tek Limited
Press Release
TBO Tek Limited, a global travel distribution platform, has announced its unaudited financial results for Q1 FY27, showing a strong performance despite geopolitical headwinds. Revenue increased 81% YoY to ₹926 Cr, and Adjusted EBITDA rose 77% YoY to ₹150 Cr. The company's Hotels + Ancillary segment saw a 50% YoY growth in GTV, and the Airlines segment reported a 14.7% YoY growth. Cash and Cash Equivalents increased by ₹392 Cr from 31st March 2026.
BSECompany Update▲ PositiveResults29 Jul 2026
Ganesh Housing Ltd-$
Transcript of Q1 FY27 Earnings Conference Call dated July 27, 2026
Ganesh Housing Ltd has announced the transcript of its Q1 FY27 Earnings Conference Call, discussing its financial highlights and business outlook. The company has made meaningful progress across various strategic initiatives and is well-positioned to capitalize on Ahmedabad's real estate growth.
BSECompany Update▲ PositiveResults29 Jul 2026
TBO TEK Ltd
Please find enclosed the Press Release on Unaudited Standalone and Consolidated Financial Results
TBO Tek Limited reported strong Q1 FY27 performance with revenue up 81% YoY and Adj. EBITDA at ₹150 Cr, up 77% YoY, driven by robust performance despite geopolitical headwinds from the middle east crisis.
NSEPress Release▲ PositiveResults29 Jul 2026
Jagsonpal Pharmaceuticals Limited
Press Release
Jagsonpal Pharmaceuticals Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue up 9% YoY, PAT up 22% YoY, and cash reserves at ₹1,700 Mn. The company has also completed the acquisition of a controlling stake in Aequitas Healthcare and concluded a ₹40 crore share buyback.
NSEPress Release▲ PositiveResults29 Jul 2026
eMudhra Limited
Press Release
eMudhra Limited reported Q1 FY27 results with revenue growth of 27.8% y-o-y, EBITDA margin at 26.2%, and PAT margin at 16.6%. The company attributed the growth to product-led growth across international markets and continued momentum in India.
BSECompany Update▲ PositiveResults29 Jul 2026
Jagsonpal Pharmaceuticals Ltd
Press Release for Unaudited Financial results for quarter ended June 30, 2026
Jagsonpal Pharmaceuticals Ltd announced Q1 FY27 results with revenue up 9%, PAT up 22%, and cash reserves at ₹1,700 Mn. The company also completed the acquisition of a controlling stake in Aequitas Healthcare and concluded a ₹40 crore share buyback.
BSECompany Update▲ PositiveResults29 Jul 2026
Jagsonpal Pharmaceuticals Ltd
Press Release for Unaudited Financial Results for quarter ended June 30, 2026
Jagsonpal Pharmaceuticals Ltd has announced its Q1 FY27 results, with revenue up 9% YoY, PAT up 22% YoY, and cash reserves at ₹1,700 Mn. The company has also completed the acquisition of a controlling stake in Aequitas Healthcare and concluded a ₹40 crore share buyback.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults29 Jul 2026
ROUTE MOBILE LIMITED
Analysts/Institutional Investor Meet/Con. Call Updates
Route Mobile Limited has informed the Exchange about the transcript of the earnings conference call for the quarter ended June 30, 2026. The company reported a 10% year-on-year revenue growth and 2% quarter-on-quarter growth. The new product portfolio grew 14% year-on-year and 11% quarter-on-quarter, outpacing the company's overall growth. The company took a decisive strategic step with the Heltar acquisition, accelerating its move up the value chain from messaging into full-stack, AI-native customer engagement.
BSECompany Update▲ PositiveResults29 Jul 2026
HFCL Ltd
This is further to our earlier announcement dated July 22, 2026.
In terms of Regulation 30 read with Para A of Part A of Schedule III to the Securities and Exchange Board of India (Listing ....
HFCL Ltd announces Q1 FY27 earnings, with highest ever quarterly revenue, profitability, and order book. The company has delivered remarkable performance, with strong order inflows and execution across core segments. The management is pleased with the first quarter's encouraging start towards accelerating growth, improving profitability, and strengthening technology leadership.
BSECompany Update▲ PositiveResults29 Jul 2026
Vedanta Iron And Steel Ltd
Please refer the enclosed Press release on the financial results of the Company for the first quarter ended June 30, 2026.
Vedanta Iron And Steel Ltd has announced its unaudited consolidated and standalone financial results for the first quarter ended June 30, 2026, with revenue growing 118% and EBITDA growing 54% year-over-year during the quarter.
BSECompany Update▲ PositiveResults29 Jul 2026
Redington Ltd
Earnings and Corporate Presentation
Redington Ltd has announced its Q1FY27 earnings, with revenue and PAT growth of 34% and 77% respectively, driven by strong performance in India and ROW businesses. The company has achieved highest ever revenue and PAT in any quarter.
BSECompany Update▲ PositiveResults29 Jul 2026
eMudhra Ltd
Press Release on the unaudited financial results for the quarter ended 30 June 2026.
eMudhra Ltd reported Q1 FY27 results with revenue growth of 27.8% y-o-y, EBITDA margin at 26.2%, and PAT margin at 16.6%. The company saw growth in its Enterprise Solutions business, driven by product-led growth in international markets and continued momentum in India.
NSEGeneral Updates▲ PositiveResults29 Jul 2026
Vakrangee Limited
General Updates
Vakrangee Limited has announced its Q1 FY2026-27 results, with a 39.3% QoQ surge in Profit After Tax to ₹2.3 crore. EBITDA margin expanded by 330 basis points. The company is well-positioned to drive scalable, profitable growth with a debt-free balance sheet and cash profit rising 16.0% to ₹6.8 crore.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults29 Jul 2026
Jagsonpal Pharmaceuticals Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Jagsonpal Pharmaceuticals Limited has announced its Q1 FY27 results, with revenue up 9% YoY, PAT up 22% YoY, and cash reserves at ₹1,700 Mn. The company has also completed the acquisition of a controlling stake in Aequitas Healthcare and concluded a ₹40 crore share buyback.